Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM
Clinical trial NCT06059326 · COMPLETED
Trial details
- NCT number
- NCT06059326
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2019-11-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.